Table 2.
Data element | Data items | ARCA registry |
---|---|---|
Administrative information | Name of center | ✓ |
Availability of informed consent | ✓ | |
Registry entry date | ✓ | |
Registry exit date and circumstances | ✓ | |
Dates of encounters | ✓ | |
Patient data | Age or birthdate | ✓ |
Gender | ✓ | |
Lifestyle factors (alcohol, smoking, employment) | ✓ | |
Disease characteristics | Diagnosis | ✓ |
Date of clinical diagnosis or first consultation | ✓ | |
Genomic information | ✓ | |
Severity/stage | ✓ | |
Milestones/outcomes/functional status | ✓ | |
Comorbidities | Relevant comorbidities (past/current) | ✓ |
Disease-related and relevant concomitant treatments | Substance | ✓ |
Dose | ✓ | |
Start date | (✓) * | |
End date | (✓) * | |
Route | ✓ | |
Schedule | × | |
Brand name | × | |
Pregnancy | Pregnancy status/outcome | × |
PROMs | Patient-reported outcomes in clinical practice | • ** |
Safety reporting | adverse events/reactions | • *** |
EMA, European Medicines Agency.
Indirect assessment by longitudinal capture of current treatment;
planned;
once closer to monitoring of drug treatments.